TN HB9057 | 2021-2022 | 112th General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on October 26 2021 - 25% progression, died in committee
Action: 2021-10-28 - P2C, ref. to Covid-19 Committee of Extraordinary Session III
Pending: House Covid-19 Committee
Text: Latest bill text (Draft #1) [PDF]
Status: Introduced on October 26 2021 - 25% progression, died in committee
Action: 2021-10-28 - P2C, ref. to Covid-19 Committee of Extraordinary Session III
Pending: House Covid-19 Committee
Text: Latest bill text (Draft #1) [PDF]
Summary
As introduced, clarifies that treatments for COVID-19 are investigational drugs, biological products, or devices for purposes of the Phil Timp-Amanda Wilcox Right to Try Act. - Amends TCA Title 29; Title 34; Title 63 and Title 68.
Title
AN ACT to amend Tennessee Code Annotated, Title 29; Title 34; Title 63 and Title 68, relative to right to try.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2021-10-28 | House | P2C, ref. to Covid-19 Committee of Extraordinary Session III |
| 2021-10-27 | House | Intro., P1C. |
| 2021-10-26 | House | Filed for introduction |
